Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort (SYPOCO 2)

Civil Hospices of Lyon

Status: Enrolling

Conditions: Post-Acute COVID-19 Syndrome

Treatments: Other: Blood sample collection

Study type: Observational

Funder types: Other

Identifiers

NCT07356570

69HCL24_0943

IDRCB (Other Identifier)

Details and patient eligibility

About

The study aims to identify clinical profiles of long-COVID patients and correlate them with immunological and molecular data in order to identify prognostic biomarkers and potential therapeutic targets.

Enrollment: 150 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Documented SARS-CoV-2 infection
• Persistent or complex post-COVID symptoms lasting more than 4 weeks or more than 3 months
• Patient referred to the EPSILON pathway or to the post-COVID rehabilitation unit
• Age ≥ 18 years
• Non-institutionalized
• Expected survival greater than 6 months

Exclusion criteria

• Refusal to participate or to share data
• Uncontrolled comorbidities
• Pregnant or breastfeeding women
• Persons under legal protection or deprived of liberty
• Not affiliated with the French national health insurance system

Trial design

150 participants in 1 patient group

Post-COVID Patient Cohort

Description:

Patients aged ≥18 years with documented SARS-CoV-2 infection and persistent or complex symptoms beyond 4 weeks or 3 months. Participants are referred to either the post-COVID rehabilitation program at Hôpital Henry Gabrielle or the EPSILON pathway at Hôpital Lyon Sud. Clinical and biological data are collected at a single inclusion visit.

Treatment:

Other: Blood sample collection